Related Experiment Video

Updated: Jun 17, 2025

Assessment of Resistance to Tyrosine Kinase Inhibitors by an Interrogation of Signal Transduction Pathways by Antibody Arrays
07:42

Assessment of Resistance to Tyrosine Kinase Inhibitors by an Interrogation of Signal Transduction Pathways by Antibody Arrays

Published on: September 19, 2018

7.9K

Non-Receptor Tyrosine Kinases: Their Structure and Mechanistic Role in Tumor Progression and Resistance

Abdulaziz M Eshaq1,2, Thomas W Flanagan3, Sofie-Yasmin Hassan4

  • 1Department of Epidemiology and Biostatistics, Milken Institute School of Public Health, George Washington University, Washington, DC 20052, USA.

Cancers
|August 10, 2024
PubMed

Insights

Protein tyrosine kinases (PTKs) are crucial signaling molecules and cancer targets. Non-receptor tyrosine kinases (NRTKs) are particularly important in cancer progression and resistance, making them key therapeutic targets.

Area of Science:

  • Molecular Biology
  • Cellular Signaling
  • Oncology

Background:

  • Protein tyrosine kinases (PTKs) are vital signaling molecules implicated in numerous human diseases, notably cancer.
  • PTKs regulate cellular functions by phosphorylating protein substrates, altering their confirmation and interactions.
  • PTKs are broadly categorized into tyrosine kinases and serine/threonine kinases, with tyrosine kinases further divided into receptor (RTKs) and non-receptor (NRTKs) subgroups.

Purpose of the Study:

  • To review the structure and mechanistic role of non-receptor tyrosine kinases (NRTKs) in tumor progression and resistance.
  • To highlight the significance of NRTKs as therapeutic targets in cancer therapy.

Main Methods:

  • Literature review focusing on NRTK structure, function, and therapeutic potential.
  • Analysis of NRTK involvement in cancer signaling pathways, progression, and drug resistance.

Main Results:

  • NRTKs are frequently overexpressed and activated in various cancer types.
  • NRTK activity, through kinase-dependent and independent mechanisms, influences diverse cellular functions.
  • NRTKs play critical roles in both tumor progression and the development of therapeutic resistance.

Conclusions:

  • NRTKs are essential regulators of cellular functions in both normal and pathological states.
  • Targeting NRTKs presents a promising strategy for enhancing cancer treatment efficacy.
  • Understanding NRTK mechanisms is crucial for developing novel anti-cancer therapies.
Keywords:
AblAckCskFakFesJakNRTKsPTKSrcSyk kinasesTec

More Related Videos

A Method for Screening and Validation of Resistant Mutations Against Kinase Inhibitors12:40

A Method for Screening and Validation of Resistant Mutations Against Kinase Inhibitors

Published on: December 7, 2014

14.9K
Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants07:39

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

45

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
12.5K
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
2.4K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.4K
Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.5K